WCK-1152

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameWCK-1152
Drug Alias NameWCK-1152WCK-1152A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionTopoisomerase IV inhibitorsDNA topoisomerase inhibitors
TargetsDNA topoisomeraseTopoisomerase IV
Therapy Area/IndicationsRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWockhardt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWockhardt Ltd
Active IndicationsN/A
Inactive IndicationsRespiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A